South Shore Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

South Shore Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	1,375 -89	-6%	-$15.3K	0.18%	124
2026 Q1	$247K	Sell	1,464 -116	-7%	-$19.8K	0.18%	123
2025 Q4	$267K	Buy	+1,580	New	+$257K	0.19%	114
2022 Q3	$492K	Sell	4,205 -35	-0.8%	-$4.35K	1.15%	26
2022 Q2	$499K	Buy	4,240 +35	+0.8%	+$4.16K	1.04%	28
2022 Q1	$548K	Sell	4,205 -2	-0%	-$261	0.89%	28
2021 Q4	$642K	Buy	4,207 +304	+8%	+$47.1K	1.05%	27
2021 Q3	$631K	Buy	3,903 +202	+5%	+$34K	1.14%	26
2021 Q2	$606K	Buy	3,701 +5	+0.1%	+$770	1.07%	25
2021 Q1	$556K	Sell	3,696 -22	-0.6%	-$3.49K	0.55%	44
2020 Q4	$563K	Buy	+3,718	New	+$531K	0.56%	47

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

South Shore Capital Advisors's IBB Position: Q2 2026 in Review

South Shore Capital Advisors reduced its iShares Biotechnology ETF (IBB) stake by 6.1% in Q2 2026, selling an estimated $15.3K and leaving 1,375 shares worth $261K. The position accounts for 0.18% of the portfolio, ranked #124.

South Shore Capital Advisors first reported a position in IBB in Q4 2020 and has held it in 11 quarters since. The position peaked at $642K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

South Shore Capital Advisors held 1,375 shares of iShares Biotechnology ETF worth $261K as of Q2 2026.
South Shore Capital Advisors sold 89 iShares Biotechnology ETF shares in Q2 2026, an estimated $15.3K.
iShares Biotechnology ETF made up 0.18% of South Shore Capital Advisors's portfolio in Q2 2026, its #124 holding.
South Shore Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 11 quarters since.
South Shore Capital Advisors's iShares Biotechnology ETF position peaked at $642K in Q4 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.